The Valley Desk

NCT05437679 · Observational study

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

Overall registry status Terminated

Conditions Biochemically Recurrent Prostate Carcinoma, Castration-resistant Prostate Cancer, High Risk Prostate Carcinoma, Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov